Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Stephen J Greene Added: 1 year ago
ESC-HFA 23 — Dr Stephen Greene (Duke University School of Medicine, US) outlines the findings from the QoL study of the TRANSFORM-HF Trial (NCT03296813). The TRANSFORM-HF trial is a randomized trial which compared torsemide to furosemide as a treatment for patients with heart failure. Around 2859 patients with heart failure were enrolled in the trial, whose clinical outcomes were measured across… View more
Author(s): Ross Campbell Added: 1 year ago
ESC-HFA 23 –Dr Ross Campbell (University of Glasgow, UK)joins us onsite to discuss the findings of the DAPA-RESIST Trial, which aimed to assess the affect of dapagliflozin as compared to metolazone in heart failure patients with diuretic resistance (NCT04860011). In this phase 3 trial, investigators studied whether SGLT2i led to greater diuresis in this patient group, as to the standard practice… View more
Author(s): Harriette Van Spall , James L Januzzi Added: 1 year ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure. Trials covered in details include: 1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy 1:42: TRACER-HF:Trientine-HCL for treatment of… View more